/PRNewswire/ The American Cancer Society and the St. Baldrick s Foundation awarded nearly $3 million to researchers fighting to end childhood cancer. The.
Researchers identify new immunotherapy treatment target for acute myeloid leukemia in children
Researchers have identified a gene expressed in children with acute myeloid leukemia (AML) that could serve as a new immunotherapy treatment target, according to a new study published today in
Blood Advances, a journal of the American Society of Hematology. The study, co-authored by researchers with Nemours Children s Health System, outlines the process and potential path for new immunotherapy drugs that improve survival and reduce treatment-related toxicity in children with AML.
Leukemia is the most common cancer in children and teens, and AML accounts for nearly one-fourth of those cases. AML is a fast-growing cancer that typically starts in immature bone marrow cells.